Posted in | News | Spectroscopy

Agilent’s Ion Mobility Technology Enhances High-Resolution Mass Spectrometry

Agilent Technologies Inc. today introduced analytical research findings using new ion mobility technology combined with a modified high-resolution iFunnel Quadrupole-Time-of-Fight LC/MS system.

The drift ion mobility system was developed in collaboration with scientists from a number of preeminent academic institutions and government laboratories. In multiple pilot studies, the prototype systems have demonstrated the ability to provide significantly greater analytical detail for complex samples compared to high-resolution mass spectrometry alone. Agilent representatives and collaborators will present their findings at the American Society for Mass Spectrometry (ASMS) conference this week.

"While high-resolution mass spectrometry has become the analytical cornerstone for proteomics, metabolomics and other research applications requiring the analysis of highly complex samples, there has also been significant interest in the use of ultra-fast orthogonal techniques to provide added dimensions of separation," said Dr. John McLean, associate professor of chemistry at Vanderbilt University's Laboratory for Structural Mass Spectrometry. "Optimized for use with Agilent's LC, IM and MS technologies, this new ion mobility system will provide researchers with greater insight and clarity than ever before."

"We have discovered that there is significant analytical utility in combining ion mobility separation technology with our high-resolution mass spectrometry systems, and we are very excited to introduce this new system to the global mass spectrometry community," said Lester Taylor, Ph.D., Agilent's director of LC/MS product marketing.

"In our presentation, collaborators will discuss how they are using this new technology to push their analytical research and discovery to new heights. Researchers working in a variety of industries-life science, drug development and manufacturing, food safety, forensics, environmental screening, and others-will also learn how they can maximize their analytical results."

Agilent collaborators include Drs. David Russell and Frederick Zinnel from Texas A&M University; Drs. Catherine Costello and Joseph Zaia from Boston University; Drs. John McLean, Jody May and Cody Goodwin from Vanderbilt University; Drs. Richard Smith and Erin Baker from the Pacific Northwest National Laboratory; Dr. Alfred Yergey and Peter Backlund from the National Institutes of Health; and Drs. Smith, May, Goodwin, Costello, and Stafford from Agilent will present their findings in oral presentations for ion mobility sessions scheduled for today and Tuesday.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Agilent Technologies, Inc.. (2019, February 27). Agilent’s Ion Mobility Technology Enhances High-Resolution Mass Spectrometry. AZoOptics. Retrieved on November 24, 2024 from https://www.azooptics.com/News.aspx?newsID=17436.

  • MLA

    Agilent Technologies, Inc.. "Agilent’s Ion Mobility Technology Enhances High-Resolution Mass Spectrometry". AZoOptics. 24 November 2024. <https://www.azooptics.com/News.aspx?newsID=17436>.

  • Chicago

    Agilent Technologies, Inc.. "Agilent’s Ion Mobility Technology Enhances High-Resolution Mass Spectrometry". AZoOptics. https://www.azooptics.com/News.aspx?newsID=17436. (accessed November 24, 2024).

  • Harvard

    Agilent Technologies, Inc.. 2019. Agilent’s Ion Mobility Technology Enhances High-Resolution Mass Spectrometry. AZoOptics, viewed 24 November 2024, https://www.azooptics.com/News.aspx?newsID=17436.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.